Guilin Kevin Peter Technology Co., Ltd – Trademark Portfolio
Entity Type: 99
Guilin Kevin Peter Technology Co., Ltd holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include KP, EVOFLEX, TRISHADE, and KEVIN PETER. The owner is based in Guilin, Guangxi.
North side of Linsu Rd., Lingui Town, Lingui Dist.
Guilin, Guangxi 541100 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guilin Kevin Peter Technology Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Guilin Kevin Peter Technology Co., Ltd have?
Guilin Kevin Peter Technology Co., Ltd has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Guilin Kevin Peter Technology Co., Ltd file in?
Guilin Kevin Peter Technology Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Guilin Kevin Peter Technology Co., Ltd's most well-known trademarks?
Guilin Kevin Peter Technology Co., Ltd's registered trademark portfolio includes well-known marks such as KP, EVOFLEX, TRISHADE, and KEVIN PETER. These are among 6 currently registered trademarks in the portfolio.
What is Guilin Kevin Peter Technology Co., Ltd's trademark registration success rate?
Guilin Kevin Peter Technology Co., Ltd has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.